Literature DB >> 2018629

Prolactin responses to haloperidol in drug-free and treated schizophrenic patients.

M Markianos1, G Sakellariou, E Bistolaki.   

Abstract

The prolactin response to 5 mg haloperidol i.m. was studied in 12 schizophrenic patients in a drug-free state and after a month treatment with haloperidol, as a possible index of dopamine receptor sensitivity and occupancy. Blood samples were taken at times 0, 60, 90 and 120 minutes. The increase in PRL observed in the drug-free state disappeared after drug treatment. The PRL plasma levels after treatment with 60 mg haloperidol per os were higher than the maximal PRL responses after 5 mg i.m. The increases in baseline PRL caused by the treatment correlated positively to the reduction in the BPRS score. The test was also performed in a group of 11 patients chronically treated with haloperidol during a daily dose of 60 mg, and 15 days after reduction of the dose to 30 mg. PRL increases after 5 mg haloperidol i.m. were observed only after reduction of the dose. It is suggested that the prolactin response to haloperidol is an index of the occupancy of receptors that are involved in the PRL releasing mechanisms, and could be used to verify their blockade by the neuroleptics, especially in patients that do not respond positively to drug treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2018629     DOI: 10.1007/bf01244450

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  10 in total

1.  Prolactin responses to neuroleptics in normal and schizophrenic subjects.

Authors:  P H Gruen; E J Sachar; G Langer; N Altman; M Leifer; A Frantz; F S Halpern
Journal:  Arch Gen Psychiatry       Date:  1978-01

2.  Relation of plasma prolactin to clinical response in schizophrenic patients.

Authors:  P G Gruen; E J Sachar; N Altman; G Langer; M A Tabrizi; F S Halpern
Journal:  Arch Gen Psychiatry       Date:  1978-10

3.  Differential prolactin responses to haloperidol and TRH in normal adult men.

Authors:  S E Hays; R T Rubin
Journal:  Psychoneuroendocrinology       Date:  1981       Impact factor: 4.905

4.  High dosage haloperidol therapy in chronic schizophrenic patients: a double-blind study of clinical response, side effects, serum haloperidol, and serum prolactin.

Authors:  N Bjørndal; M Bjerre; J Gerlach; P Kristjansen; G Magelund; I H Oestrich; J Waehrens
Journal:  Psychopharmacology (Berl)       Date:  1980-01       Impact factor: 4.530

5.  Variability of prolactin response to intravenous and intramuscular haloperidol in normal adult men.

Authors:  R T Rubin; S E Hays
Journal:  Psychopharmacology (Berl)       Date:  1979-03-14       Impact factor: 4.530

6.  Neuroendocrine tests during treatment with neuroleptic drugs I. Plasma prolactin response to haloperidol challenge.

Authors:  T Kolakowska; L Braddock; D Wiles; M Franklin; M Gelder
Journal:  Br J Psychiatry       Date:  1981-11       Impact factor: 9.319

7.  Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response.

Authors:  H Y Meltzer; D A Busch; V S Fang
Journal:  Psychiatry Res       Date:  1983-08       Impact factor: 3.222

8.  Serum prolactin response to chlorpromazine and psychopathology in schizophrenics: implications for the dopamine hypothesis.

Authors:  H Y Meltzer; D Busch
Journal:  Psychiatry Res       Date:  1983-08       Impact factor: 3.222

9.  Abnormal prolactin response to haloperidol challenge in men with schizophrenia.

Authors:  N A Keks; D L Copolov; B S Singh
Journal:  Am J Psychiatry       Date:  1987-10       Impact factor: 18.112

10.  Clinical state, plasma levels of haloperidol and prolactin: a correlation study in chronic schizophrenia.

Authors:  V A Rao; M Bishop; A Coppen
Journal:  Br J Psychiatry       Date:  1980-12       Impact factor: 9.319

  10 in total
  1 in total

Review 1.  Prolactin and psychopathology in schizophrenia: a literature review and reappraisal.

Authors:  Ravi Philip Rajkumar
Journal:  Schizophr Res Treatment       Date:  2014-03-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.